Published in Ann Thorac Surg on December 01, 2005
Resveratrol attenuates behavioral impairments and reduces cortical and hippocampal loss in a rat controlled cortical impact model of traumatic brain injury. J Neurotrauma (2010) 1.10
Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response (2007) 0.89
Resveratrol neuroprotection in stroke and traumatic CNS injury. Neurochem Int (2015) 0.87
Neuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oil. Nutrients (2014) 0.86
Sirt1's complex roles in neuroprotection. Cell Mol Neurobiol (2009) 0.84
Organ-Protective Effects of Red Wine Extract, Resveratrol, in Oxidative Stress-Mediated Reperfusion Injury. Oxid Med Cell Longev (2015) 0.83
The time course of action of two neuroprotectants, dietary saffron and photobiomodulation, assessed in the rat retina. Am J Neurodegener Dis (2013) 0.81
Resveratrol inhibits matrix metalloproteinases to attenuate neuronal damage in cerebral ischemia: a molecular docking study exploring possible neuroprotection. Neural Regen Res (2015) 0.80
Stuck at the bench: Potential natural neuroprotective compounds for concussion. Surg Neurol Int (2011) 0.78
Resveratrol preconditioning induces cerebral ischemic tolerance but has minimal effect on cerebral microRNA profiles. J Cereb Blood Flow Metab (2016) 0.77
Therapeutic Effects of Traditional Chinese Medicine on Spinal Cord Injury: A Promising Supplementary Treatment in Future. Evid Based Complement Alternat Med (2016) 0.77
Resveratrol or higher arterial blood pressure protects the spinal cord from ischemia-reperfusion injury? Ann Thorac Surg (2006) 0.76
Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation (2016) 0.75
Resveratrol can both enhance and relax adrenergic contractions of the rat tail artery. J Smooth Muscle Res (2016) 0.75
Invited commentary. Ann Thorac Surg (2005) 0.75
Natural polyphenols and spinal cord injury. Iran Biomed J (2014) 0.75
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet (2006) 12.98
Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet (2007) 6.76
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest (2005) 5.51
Hypothyroidism after sunitinib treatment for patients with gastrointestinal stromal tumors. Ann Intern Med (2006) 4.52
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Clinical activity of mTOR inhibition with sirolimus in malignant perivascular epithelioid cell tumors: targeting the pathogenic activation of mTORC1 in tumors. J Clin Oncol (2010) 4.01
Evidence-based guidelines for cardiovascular disease prevention in women. Circulation (2004) 3.39
The renal papilla is a niche for adult kidney stem cells. J Clin Invest (2004) 3.03
Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial. J Am Coll Cardiol (2006) 2.88
The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant (2013) 2.71
Surgical management of advanced gastrointestinal stromal tumors after treatment with targeted systemic therapy using kinase inhibitors. J Clin Oncol (2006) 2.66
Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol (2004) 2.62
Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur J Heart Fail (2010) 2.40
Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure. Circulation (2012) 2.17
Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant (2005) 2.05
Molecular target modulation, imaging, and clinical evaluation of gastrointestinal stromal tumor patients treated with sunitinib malate after imatinib failure. Clin Cancer Res (2009) 1.99
Proliferation and migration of label-retaining cells of the kidney papilla. J Am Soc Nephrol (2009) 1.99
Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumors. Clin Cancer Res (2007) 1.94
Combination mTOR and IGF-1R inhibition: phase I trial of everolimus and figitumumab in patients with advanced sarcomas and other solid tumors. Clin Cancer Res (2010) 1.89
Efficacy and safety of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of imatinib and sunitinib: a multicenter phase II trial. J Clin Oncol (2012) 1.84
Adipose tissue inflammation and adiponectin resistance in patients with advanced heart failure: correction after ventricular assist device implantation. Circ Heart Fail (2012) 1.79
Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support. Circulation (2014) 1.76
The cost of medical management in advanced heart failure during the final two years of life. J Card Fail (2008) 1.71
Safety and usefulness of composite grafts for total arterial myocardial revascularization: a prospective randomized evaluation. J Thorac Cardiovasc Surg (2003) 1.69
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69
The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J Am Coll Cardiol (2007) 1.63
A preeclampsia-like syndrome characterized by reversible hypertension and proteinuria induced by the multitargeted kinase inhibitors sunitinib and sorafenib. J Natl Cancer Inst (2008) 1.63
Phase I dose-escalation and pharmacokinetic study of dasatinib in patients with advanced solid tumors. Clin Cancer Res (2009) 1.63
Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database. Circulation (2006) 1.62
Evidence-based guidelines for cardiovascular disease prevention in women. J Am Coll Cardiol (2004) 1.59
Heart transplant and left ventricular assist device costs. J Heart Lung Transplant (2005) 1.55
Significance of postoperative acute renal failure after continuous-flow left ventricular assist device implantation. Ann Thorac Surg (2012) 1.55
Effect of donor age on long-term survival following cardiac transplantation. J Card Surg (2006) 1.54
Preoperative assessment of high-risk candidates to predict survival after heart transplantation. Circ Heart Fail (2013) 1.53
Small molecule tyrosine kinase inhibitor and depression. J Clin Oncol (2008) 1.51
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement. Arterioscler Thromb Vasc Biol (2004) 1.49
Laser energy source in surgical atrial fibrillation ablation: preclinical experience. Ann Thorac Surg (2006) 1.47
Which patient, which pump? J Heart Lung Transplant (2003) 1.46
Long-term outcomes with a minimally invasive approach for resection of cardiac masses. Ann Thorac Surg (2010) 1.45
Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma. Cancer (2014) 1.43
Totally endoscopic atrial septal defect repair with robotic assistance. Circulation (2003) 1.40
Safety of anticoagulation reversal in patients supported with continuous-flow left ventricular assist devices. ASAIO J (2015) 1.39
Isolation and culture of human muscle-derived stem cells able to differentiate into myogenic and neurogenic cell lineages. Lancet (2004) 1.39
Staged percutaneous coronary intervention and minimally invasive valve surgery: results of a hybrid approach to concomitant coronary and valvular disease. J Thorac Cardiovasc Surg (2013) 1.38
A phase I study of single-agent nilotinib or in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors. Clin Cancer Res (2009) 1.37
Surgical ventricular restoration: the RESTORE Group experience. Heart Fail Rev (2004) 1.37
Coronary artery bypass grafting in patients with low ejection fraction. Circulation (2005) 1.36
Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg (2004) 1.34
Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg (2002) 1.33
Robotic techniques improve quality of life in patients undergoing atrial septal defect repair. Ann Thorac Surg (2004) 1.29
Durable staged hybrid ablation with thoracoscopic and percutaneous approach for treatment of long-standing atrial fibrillation: a 30-month assessment with continuous monitoring. J Thorac Cardiovasc Surg (2012) 1.29
Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience. J Thorac Cardiovasc Surg (2004) 1.23
Minimally invasive versus sternotomy approach for mitral valve surgery: a propensity analysis. Ann Thorac Surg (2010) 1.23
Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg (2003) 1.19
Association of device surface and biomaterials with immunologic sensitization after mechanical support. J Thorac Cardiovasc Surg (2008) 1.16
Current issues in gastrointestinal stromal tumors: incidence, molecular biology, and contemporary treatment of localized and advanced disease. Curr Opin Gastroenterol (2007) 1.16
Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness. Circulation (2005) 1.14
Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol (2005) 1.13
Familial polyposis coli: clinical manifestations, evaluation, management and treatment. Mt Sinai J Med (2004) 1.13
Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction. J Heart Lung Transplant (2012) 1.13
Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery. J Heart Lung Transplant (2005) 1.10
Leiomyosarcoma of the inferior vena cava: survival after aggressive management. Ann Surg Oncol (2007) 1.10
Multimodality treatment of mesenteric desmoid tumours. Eur J Cancer (2008) 1.09
Does robotic technology make minimally invasive cardiac surgery too expensive? A hospital cost analysis of robotic and conventional techniques. J Card Surg (2005) 1.07
Imaging features of bone metastases in patients with gastrointestinal stromal tumors. Diagn Interv Radiol (2012) 1.06
Risk analysis of deep sternal wound infections and their impact on long-term survival: a propensity analysis. Ann Plast Surg (2008) 1.06
Total arterial myocardial revascularization with composite grafts improves results of coronary surgery in elderly: a prospective randomized comparison with conventional coronary artery bypass surgery. Circulation (2003) 1.05
Effect of left ventricular assist device infection on post-transplant outcomes. J Heart Lung Transplant (2009) 1.05
Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma. Eur J Cancer (2009) 1.04
Endovascular edge-to-edge mitral valve repair: short-term results in a porcine model. Circulation (2003) 1.04
Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948). PLoS One (2012) 1.03
A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg (2003) 1.03
Preoperative serum albumin levels predict 1-year postoperative survival of patients undergoing heart transplantation. Circ Heart Fail (2013) 1.02
Evolution of cannulation techniques for minimally invasive cardiac surgery: a 10-year journey. Innovations (Phila) (2012) 1.02
Implantation of a left ventricular assist device and the hub-and-spoke system in treating acute cardiogenic shock: who survives? J Thorac Cardiovasc Surg (2003) 1.01
Epithelioid angiosarcoma of the uterus: a review of management. Arch Gynecol Obstet (2008) 1.01
The effect of ischemic time on survival after heart transplantation varies by donor age: an analysis of the United Network for Organ Sharing database. J Thorac Cardiovasc Surg (2007) 1.00
Thoracic surgery workforce: snapshot at the end of the twentieth century and implications for the new millennium. Ann Thorac Surg (2002) 1.00
A novel family-based intervention trial to improve heart health: FIT Heart: results of a randomized controlled trial. Circ Cardiovasc Qual Outcomes (2008) 1.00
Cytoreductive surgery in patients with metastatic gastrointestinal stromal tumor treated with sunitinib malate. Ann Surg Oncol (2009) 1.00
Mechanical support for the failing cardiac allograft: a single-center experience. J Heart Lung Transplant (2003) 0.98
Endoscopic computer-enhanced mediastinal mass resection using robotic technology. Heart Surg Forum (2003) 0.98
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma. Cancer (2002) 0.98
Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions. Circulation (2002) 0.98
Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant (2006) 0.97
beta(2)-Adrenergic stimulation attenuates left ventricular remodeling, decreases apoptosis, and improves calcium homeostasis in a rodent model of ischemic cardiomyopathy. J Pharmacol Exp Ther (2006) 0.96
Long-term survival and quality of life in cardiac surgical patients with prolonged intensive care unit length of stay. Ann Thorac Surg (2002) 0.96
Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors. Cancer (2013) 0.95
Administration of octreotide for management of postoperative high-flow chylothorax. Ann Vasc Surg (2007) 0.95
Deletion of hensin/DMBT1 blocks conversion of beta- to alpha-intercalated cells and induces distal renal tubular acidosis. Proc Natl Acad Sci U S A (2010) 0.95
Role of the Abiomed BVS 5000 device for short-term support and bridge to transplantation. ASAIO J (2004) 0.95
Reduction ascending aortoplasty: midterm follow-up and predictors of redilatation. Ann Thorac Surg (2006) 0.94